Fundz

CytoDyn Appoints Robert E. Hoffman as Chief Financial Officer

PUBLIC · CYDYMay 06, 2025

Position

Chief Financial Officer

Company

CytoDyn

Robert E. Hoffman
VancouverBiotechnologyHealthcareHealth CareTherapeutics

Description

CytoDyn Inc. has announced the appointment of Robert E. Hoffman as Chief Financial Officer, effective May 15, 2025

Who to call at CytoDyn, and when

A new leader at CytoDyn brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day CytoDyn raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoDyn, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoDyn. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoDyn

Location

1111 Main Street

Vancouver, Washington, United States

About

CytoDyn is in late-stage clinical development of leronlimab, a CCR5 receptor antagonist, to be used as a platform drug for various therapeutic indications, including NASH, NASH/HIV, oncology, and HIV. The CCR5 receptor is a protein located on the surface of various cells including white blood cells, stellate cells which produce scar tissue in the liver, cells that undergo malignant transformation, and is the predominant co-receptor needed for certain strains of HIV to infect healthy T-cells. The CCR5 receptor serves as a receptor for chemical attractants called chemokines. Chemokines are the key orchestrators of leukocyte trafficking by attracting immune cells to the sites of inflammation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoDyn changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Robert
Senior decision-maker at this company
••••••••@••••••••

See Robert's verified email →

Minxiu
Senior decision-maker at this company
••••••••@••••••••

See Minxiu's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for CytoDyn's next move

Learn about Strategic plan

CytoDyn changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.